Cigna Corporation (CI) is a Medical - Healthcare Plans company in the Healthcare sector, currently trading at $272.60. It has a SharesGrow Score of 62/100, indicating a above average investment profile with 4 out of 7 criteria passed.
SharesGrow calculates the intrinsic value of CI = $810.27 (+197.2% from the current price, the stock appears undervalued). Analyst consensus target is CI = $326 (+19.5% upside).
Valuation: CI trades at a trailing Price-to-Earnings (P/E) of 12.4 (S&P 500 average ~25) with a forward Price/Earnings-to-Growth (PEG) of 1.2.
Financials: revenue is $275.0B, +15.4%/yr average growth. Net income is $6.0B, growing at +5.7%/yr. Net profit margin is 2.2% (thin). Gross margin is 9.5% (-72.9 pp trend).
Balance sheet: total debt is $31.5B against $41.7B equity (Debt-to-Equity (D/E) ratio 0.75, moderate). Current ratio is 0.85 (tight liquidity). Debt-to-assets is 19.9%. Total assets: $157.9B.
Analyst outlook: 31 / 39 analysts rate CI as buy (79%) — strong consensus.
SharesGrow 7-Criteria breakdown: Value 80/100 (Pass), Growth 73/100 (Pass), Past 100/100 (Pass), Health 33/100 (Fail), Moat 38/100 (Fail), Future 79/100 (Pass), Income 30/100 (Fail).
